Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs

作者: Bradley R. Schmidt , Nita W. Glickman , Dennis B. DeNicola , Amalia E. de Gortari , Deborah W. Knapp

DOI: 10.2460/JAVMA.2001.218.1783

关键词:

摘要: Objective—To evaluate the use of piroxicam for treatment oral squamous cell carcinoma in dogs. Design—Prospective case series. Animals—17 dogs with measurable carcinoma. Procedure—Dogs were treated at a dosage 0.3 mg/kg (0.14 mg/lb) body weight, PO, every 24 hours until progressive disease or unacceptable signs toxicosis developed dog died. Results—One had complete remission (maxillary tumor), and 2 partial remissions (lingual tumor tonsillar tumor). An additional 5 stable disease, including 1 maxillary tumor, mandibular tumors, tumors. Variables associated response not identified. Median mean times to failure 3 that 180 223 days, respectively. 102 Time was positively negatively associa...

参考文章(30)
R J Todoroff, R S Brodey, Oral and pharyngeal neoplasia in the dog: a retrospective survey of 361 cases. Javma-journal of The American Veterinary Medical Association. ,vol. 175, pp. 567- 571 ,(1979)
B E Kitchell, W Shapiro, G Theilen, C G Couto, T W Fossum, Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs. Javma-journal of The American Veterinary Medical Association. ,vol. 193, pp. 1530- 1533 ,(1988)
Bradley Rl, MacEwen Eg, Loar As, Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. Javma-journal of The American Veterinary Medical Association. ,vol. 184, pp. 460- ,(1984)
Carlos Rodriguez, Stephen M Griffey, Bruce R. Madewell, Alain P Theon, ANALYSIS OF PROGNOSTIC FACTORS AND PATTERNS OF FAILURE IN DOGS WITH MALIGNANT ORAL TUMORS TREATED WITH MEGAVOLTAGE IRRADIATION Javma-journal of The American Veterinary Medical Association. ,vol. 210, pp. 778- 784 ,(1997)
Withrow Sj, Elmslie Re, Vail Dm, Ogilvie Gk, Moore As, Straw Rc, Cooper Mf, Obradovich Je, Dickinson K, Efficacy of mitoxantrone against various neoplasms in dogs. Javma-journal of The American Veterinary Medical Association. ,vol. 198, pp. 1618- 1621 ,(1991)
Buhles Wc, Theilen Gh, Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma. American Journal of Veterinary Research. ,vol. 34, pp. 289- 291 ,(1973)
S.J. Withrow, G.K. Ogilvie, B.E. Powers, S.M. LaRue, P.D. Schwarz, R.C. Straw, J. Berg, L.G. Carpenter, Squamous cell carcinoma of the tongue in 10 dogs Journal of The American Animal Hospital Association. ,(1993)
Han Li, Alanna K. Rahm, Dennis J. Ahnen, Alan L. Stoumen, Tyler S. Finn, Benjamin H. Fryer, Gary A. Piazza, Rifat Pamukcu, Apoptosis Primarily Accounts for the Growth-inhibitory Properties of Sulindac Metabolites and Involves a Mechanism That Is Independent of Cyclooxygenase Inhibition, Cell Cycle Arrest, and p53 Induction Cancer Research. ,vol. 57, pp. 2452- 2459 ,(1997)
Lawrence J. Marnett, Aspirin and the Potential Role of Prostaglandins in Colon Cancer Cancer Research. ,vol. 52, pp. 5575- 5589 ,(1992)
Marjory B. Brooks, Robert E. Matus, Connie E. Leifer, Alan A. Alfieri, Amiya K. Patnaik, Chemotherapy Versus Chemotherapy Plus Radiotherapy in the Treatment of Tonsillar Squamous Cell Carcinoma in the Dog Journal of Veterinary Internal Medicine. ,vol. 2, pp. 206- 211 ,(1988) , 10.1111/J.1939-1676.1988.TB00318.X